Thalidomide produces benefits in some patients with tumoursBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7309.360/a (Published 18 August 2001) Cite this as: BMJ 2001;323:360
- Scott Gottlieb
- New York
The drug thalidomide, which led to severe birth defects in the 1950s when it was used during pregnancy to prevent morning sickness, has been shown to produce benefits in patients with myelodysplastic syndrome and to prevent the progression of some forms of myeloma, according to two separate studies.
Despite its reputation, the drug is gaining favour in the treatment of a variety of cancers and infectious diseases. In one study, Dr Azra Raza, from Rush-Presbyterian-St …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial